Sichuan Hebang Biotechnology Co Ltd (SHG:603077) — Market Cap & Net Worth
Market Cap & Net Worth: Sichuan Hebang Biotechnology Co Ltd (603077)
Sichuan Hebang Biotechnology Co Ltd (SHG:603077) has a market capitalization of $3.84 Billion (CN¥26.23 Billion) as of May 7, 2026. Listed on the SHG stock exchange, this China-based company holds position #4272 globally and #756 in its home market, demonstrating a 2.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sichuan Hebang Biotechnology Co Ltd's stock price CN¥2.97 by its total outstanding shares 8831672728 (8.83 Billion). Analyse 603077 cash generation efficiency to see how efficiently the company converts income to cash.
Sichuan Hebang Biotechnology Co Ltd Market Cap History: 2015 to 2026
Sichuan Hebang Biotechnology Co Ltd's market capitalization history from 2015 to 2026. Data shows growth from $3.80 Billion to $3.84 Billion (0.83% CAGR).
Sichuan Hebang Biotechnology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sichuan Hebang Biotechnology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.31x
Sichuan Hebang Biotechnology Co Ltd's market cap is 0.31 times its annual revenue
Latest Price to Earnings (P/E) Ratio
83.79x
Sichuan Hebang Biotechnology Co Ltd's market cap is 83.79 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $3.80 Billion | $2.86 Billion | $239.87 Million | 1.33x | 15.82x |
| 2016 | $2.89 Billion | $3.46 Billion | $317.81 Million | 0.84x | 9.10x |
| 2017 | $2.50 Billion | $4.74 Billion | $517.54 Million | 0.53x | 4.82x |
| 2018 | $2.05 Billion | $6.01 Billion | $363.09 Million | 0.34x | 5.63x |
| 2019 | $1.87 Billion | $5.97 Billion | $516.85 Million | 0.31x | 3.62x |
| 2020 | $1.79 Billion | $5.26 Billion | $40.94 Million | 0.34x | 43.80x |
| 2021 | $4.31 Billion | $9.99 Billion | $3.02 Billion | 0.43x | 1.43x |
| 2022 | $3.86 Billion | $13.04 Billion | $3.81 Billion | 0.30x | 1.01x |
| 2023 | $3.05 Billion | $8.82 Billion | $1.28 Billion | 0.35x | 2.38x |
| 2024 | $2.64 Billion | $8.55 Billion | $31.46 Million | 0.31x | 83.79x |
Competitor Companies of 603077 by Market Capitalization
Companies near Sichuan Hebang Biotechnology Co Ltd in the global market cap rankings as of May 7, 2026.
Key companies related to Sichuan Hebang Biotechnology Co Ltd by market ranking:
- BASF SE (F:BASA): Ranked #537 globally with a market cap of $49.38 Billion USD ( €42.24 Billion EUR).
- BASF SE (XETRA:BAS): Ranked #580 globally with a market cap of $45.45 Billion USD ( €38.87 Billion EUR).
- Ningxia Baofeng Energy Group Co Ltd (SHG:600989): Ranked #821 globally with a market cap of $32.36 Billion USD ( CN¥221.17 Billion CNY).
- Hengli Petrochemical Co Ltd (SHG:600346): Ranked #1105 globally with a market cap of $23.54 Billion USD ( CN¥160.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #537 | BASF SE | F:BASA | $49.38 Billion | €12.90 |
| #580 | BASF SE | XETRA:BAS | $45.45 Billion | €52.52 |
| #821 | Ningxia Baofeng Energy Group Co Ltd | SHG:600989 | $32.36 Billion | CN¥30.16 |
| #1105 | Hengli Petrochemical Co Ltd | SHG:600346 | $23.54 Billion | CN¥22.85 |
Sichuan Hebang Biotechnology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Sichuan Hebang Biotechnology Co Ltd's market cap moved from $3.80 Billion to $ 3.84 Billion, with a yearly change of 0.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥3.84 Billion | +31.42% |
| 2025 | CN¥2.92 Billion | +10.78% |
| 2024 | CN¥2.64 Billion | -13.56% |
| 2023 | CN¥3.05 Billion | -20.94% |
| 2022 | CN¥3.86 Billion | -10.42% |
| 2021 | CN¥4.31 Billion | +140.14% |
| 2020 | CN¥1.79 Billion | -4.05% |
| 2019 | CN¥1.87 Billion | -8.64% |
| 2018 | CN¥2.05 Billion | -18.07% |
| 2017 | CN¥2.50 Billion | -13.69% |
| 2016 | CN¥2.89 Billion | -23.77% |
| 2015 | CN¥3.80 Billion | -- |
End of Day Market Cap According to Different Sources
On May 7th, 2026 the market cap of Sichuan Hebang Biotechnology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.84 Billion USD |
| MoneyControl | $3.84 Billion USD |
| MarketWatch | $3.84 Billion USD |
| marketcap.company | $3.84 Billion USD |
| Reuters | $3.84 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sichuan Hebang Biotechnology Co Ltd
Sichuan Hebang Biotechnology Corporation Limited provides agricultural, chemical, and new material products. It offers biological pesticides, biological veterinary drugs, and methionine products; and sodium carbonate, ammonium chloride, soda ash, diglyphosate, glyphosate, and brine. The company provides original glass and smart glass, special glass, low-e coated glass, and photovoltaic packaging … Read more